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ABSTRACT
INTRODUCTION: Cholera is a serious Public Health Emergencies of International Concern (PHEIC). The recurrence of 
outbreaks depicts lack of appropriate control and prevention, thereby contributing to high morbidity, mortality and 
socioeconomic burden. The clinical setting, aside from treatment of the infected, plays a big role in the ultimate 
prevention and control of the disease. 
AIM: This article highlights the necessary prevention and control practices in low-resource clinical settings.
METHODOLOGY: We extracted relevant articles from various databases such as PubMed, Google Scholar and African 
Journal Online(AJOL) and summarized them.
RESULT: Cholera caused by the organism, Vibrio cholera is of great global burden and majority of cases are in poor and low 
resource setting like Nigeria, where there are challenges with water supply and sanitation. The key preventative and 
control strategy in clinical setting include clinical and administrative policy toward cholera prevention and control, rapid 
case identification, compliance with Standard Precaution, adoption of Transmission Based Precautions for patient 
isolation, contact tracing and treatment, effective case referral system, cholera education and enlightenment of health 
workers and the community.
CONCLUSION: With the current wave of cholera in many countries, there is need for health practitioners to upgrade their 
skills in both clinical and infection prevention and control practices.
KEYWORDS: Cholera, Nigeria, Clinical setting, Infectious disease, infection control.
Original Article 
INTRODUCTION
holera is not a new disease, in the last 
Ctwo centuries, it has caused seven pandemics and still ravages many 
communities globally, particularly in Africa 
1
and Asia.  Mortality in recent times in certain 
communities have approached alarming 
rates witnessed during one of the  highlighted 
pandemics experienced a hundred year ago; 
an example is the outbreak in Zimbabwe 
2
between 2008–2009.  Currently the disease is 
considered a Public Health Emergencies of 
International Concern (PHEIC). 
Aside the enormous implication on the 
community setting, it poses a serious 
challenge in clinical settings especially the 
predisposition to infection in advent of an 
epidemic among the health workforce 
(HWF), leading to high morbidity and 
mortality among the overburdened health 
4-6workers.
Furthermore, in some communities the 
disease is endemic thus exposing the HWF 
constantly to the risk of the disease. For 
example in Democratic Republic of Congo 
(DRC), about 9% of the country's population 
live in areas where the incidence of the 
4disease is higher than 1/1000.–
We write to highlight the necessary 
prevention and control practices in low-
resource clinical settings due to the potential 
effect on the health workforce and health 
system during emergence of an epidemic or 
the endemic pattern in some regions.
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HISTORY
Cholera causing organism-Vibrocholerae 
was rst isolated by Italian anatomist, Filippo 
Pacini, in 1854 from histological examination 
on the intestinal mucosa of autopsied cholera 
infected patients while Robert Koch, a 
German physician in 1883 also conrmed the 
disease is caused by this bacillus while 
7working in Egypt and India.  The disease was 
d i s c o v e r e d  t o  b e  a s s o c i a t e d  w i t h 
contaminated water by British physician, 
John Snow (father of Epidemiology) in 1854 
during the outbreak of cholera epidemic at 
7Broad Street Pump in London. 
EPIDEMIOLOGY
There is a high global burden of the disease, 
according to World Health Organisation 
(WHO),who had reported 1.3 to 4.0 million 
cases annually and about 21 000 to 143 000 
8
deaths.
In 2011, a resolution was adopted at the 64th 
World Health Assembly to recognize the re-
emergence of cholera as a weighty public 
health threat requiring a comprehensive and 
9integrated control.  That same year, WHO 
reported cumulative cholera cases of 589, 854 
with 7,816 deaths in 58 countries (case fatality 
rate(CFR) of 1.3%); this was 85% higher than 
10
2010 report.   Out of the 58 countries reported 
for cholera epidemics, 27 were African 
countries. Globally, 33 countries recorded 
cholera deaths while 23 out of the 33 countries 
emanated from Africa, this represented 53% of 
10
the total global deaths.  Two American 
countries, Dominican Republic and Haiti, were 
responsible for 41% of total global death. 
Majority of the deaths were clustered in low 
resource countries where there were poor 
access to healthcare services, water, sanitation, 
10
hygiene and poorer sewage management.
A large number of the cases in recent times 
arise in sub Saharan Africa with Nigeria 
8,11
contributing a signicant amount.   Deaths 
attributed to cholera were 5,127 out of 154,910 
cases reported in Nigeria between 2004 to 
12 
2016 with a CFR of 3.3%. Nigeria had the 
highest cholera cases within West and Central 
Africa regions in 2014, with 35,996 cases 
representing 39% of total in the region.
There are recently reported outbreak among 
internally displaced people of refugee camps 
in North East and other communities within 
K w a r a  S t a t e  i n  t h e  N o r t h  C e n t r a l 
13
zone.  According to Nigeria Centre for 
Disease Control (NCDC), cholera in 2015 was 
accountable for 5,301 cases with 29 laboratory 
conrmed, 186 deaths (3.51% CFR) across 101 
LGA in 18 states and Federal Capital Territory 
14
(FCT).  In 2016, it accounted for 768 cases and 
32 deaths (4.17% CFR) across 57 Local 
Government Area (LGA) in 14 states. In 2017, 
between week 1 to 34 (August 21 – 27), cholera 
was responsible for 1,198 cases and  32 deaths 
(2.67% CFR) across 47 LGA in 16 states; 
comparable to 2016, week 1 to 34 (August 22 – 
28), cholera was associated with 402 cases and 
13 deaths (3.32% CFR) across 34 LGA in 11 
states. The pattern between 2015 and 2016 
showed an impressive decrease, but between 
year 2016 and 2017, within 1 to 34 weeks, 
showed signicant increase in reported cases 
(suspected or probable), deaths and spread 
across LGA and states. 
Cholera is transmitted through consumption 
of contaminated food or water, with the 
sewage of an infected person or people. 
Provision of safe water, healthy sanitation 
and good hygienic practices are essential in 
prevent ing  and contro l l ing  cholera 
15
particularly at the community level.
MICROBIOLOGY
Cholera is an acute diarrhoeal disease, caused 
by a comma (or curved) shaped gram 
16
negative bacterium called Vibrio cholerae.   
There are above 200 serotypes categorized by 
the lipopolysaccharide O antigen on their cell 
surface, but 2 serotypes, O1 and O139, are 
known to cause epidemic and pandemic 
cholera. Serotype O1 is subsequently divided 
into Classical and El tor biotypes, both known 
for the cholera toxin (CT) and toxin-co-
16
regulated pilus (TCP), the virulent factors.  
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The bacteria can be isolated and identied 
from stool specimen through:
- Rapid Diagnostic Test, benecial for 
quick identication and monitoring 
during outbreak cases, with about 24 
developed since 1990, but limited by 
17,18
sensitivity and specicity.  
- Microbial culture using thiosulfate citrate 
bile salts sucrose (TCBS) agar, agar of 
choice, and others; this is the gold standard 
and essential for antimicrobial sensitivity 
17to track antibiotic resistance species.
- Molecular characterization using 
Polymerase Chain Reaction, still at the 
early stage with many tools utilising the 
19,20
technology being developed.  This has 
higher sensitivity and specicity in 
addition to rapidly diagnosis of the disease 
even with low quantum of bacteria load in 
sample. It uses PCR detection based on 
magnetic nanoparticles for rapid detection 
of bacterial DNA of cholera organism.
It is mainly Cary Blair and Alkaline Peptone 
Water (APW) that is used as transport 
medium of the sample, though there are 
others such as Stuart and Amies transport 
media, lter paper and  bile peptone 
17
medium.
The prevention and control in hospital setting 
have some unique practices which are 
necessary for effective intervention, breaking 
the chain of transmission and reducing 
fatality. Aside its capacity of being an 
effective contagion, it has been documented 
25,26
to show increasing antibiotic resistance.
A l t h o u g h ,  t h e r e  a r e  d o c u m e n t e d 
effectiveness of Quinolones (Ciprooxacin, 
Noroxacin and Ooxacin) in treating 
cholera from studies conducted in Argentina, 
Bangladesh, India, Peru, and Thailand.  
However studies across Africa, Asia and 
America have indicated V. cholerae resistant 
strains emerging against quinolones; studies 
on V. cholerae O1 strains conducted at 
Infectious Diseases Hospital Calcutta, India 
with documented 38.8% and 25% resistance 
27to quinolones respectively in 1999 and 2000.
I N F E C T I O N  P R E V E N T I O N  A N D 
CONTROL
Case identication is very important 
especially by primary health workers, who 
are mostly the rst responders to establish 
contact with infected patients, and more 
29likely to see many of these cases.  It is 
therefore imperative that they are educated 
and empowered to ensure there is proper 
identication, prompt intervention and 
appropriate compliance with infection 
control standards.
Thereafter, efforts should be directed to apply 
Contact Precautions to prevent further 
transmission. Contact Precaution is the 
transmission based precaution applied for 
probable, suspected or conrmed cholera 
29-31
cases admitted within the hospitals.  
Transmission Based Precautions are 
additional infection control practices (safety 
precautions), beyond standard precautions, 
used to prevent transmission of infectious 
29-32
diseases.  There are three types: contact, 
droplets and airborne based on the three 
major routes of transmission – contact (direct 
or indirect contact), droplet particles of 
respiratory elements between 5 and 30 μm or 
more (about 100 μm) and Airborne particles 
30-33of respiratory aerosols below 5 μm .
Ideally, a single patient room is used as the 
isolation room for contact precaution to admit 
patient, but where this is not possible, putting 
patients with the same disease in the same 
room and adhering to appropriate bed 
spacing of 1m or 1.5m can be adopted. The 
Personal Protective Equipments (PPE) used 
for contact precaution are hand gloves, 
gowns while face masks and/or goggles are 
used for suspicion of splashes from vomiting 
or diarrhoea (common presenting symptoms 
of cholera). Hand hygiene, through hand 
washing with owing water and soap or hand 
rubbing with alcohol gel when appropriate, 
should be made a standard practice within all 
health facilities and its use in donning & 
dofng of PPE, 5 Moments of Hand Hygiene 
and other point of care practices should be 
32,34,35
effectively implemented.
Nigerian Journal of Medicine, Vol. 27  No.  1, January - March, 2018,  ISSN 1115-2613
17
Care of  the hospital  environment is 
important; housekeepers or hospital cleaners 
trained on infection control practices peculiar 
to their job and specic infectious diseases 
should be assigned to the cleaning, 
disinfection and terminal decontamination of 
the isolation room, and subsequently 
33
monitored for compliance.  The yellow 
coloured medical waste bin should be used in 
the contact precaution isolation room; single 
use bed linen is preferable but when not 
possible, dirty bed linen should be cleaned 
and disinfected appropriately; while soiled 
bed linen should be discarded (not to be 
reused), after use, into the yellow coloured 
3 3medical waste bin.  There should be 
adequate and prompt cleaning, disinfection 
and/or sterilization of all medial apparatus 
and equipment within the isolation room, 
33whether used or unused.  Usually, the 
isolation room is recommended safe for 
further admission based on the information 
on the disinfectant manuals or policy 
guidelines of the hospital, Ministry of Health 
(MOH), Association for Professionals in 
Infection Control and Epidemiology(APIC), 
NCDC, WHO or other authorities on 
infection prevention and control. The number 
of staffs and relatives that access index 
patient's Contact Precaution Isolation Room 
should be limited to those who are essentially 
involved in the patient's care. A log book 
should be opened to document inow and 
outow of essential staffs and relatives 
visiting patients while information on notice 
of occurrences of symptoms peculiar to 
33cholera must be promptly reported.
All contacts of probable, suspected or 
conrmed patients should be traced and 
monitored for appropriate testing, restrictions 
33
and other interventions as required.
Referral System: Referral of index patient to 
another hospital should be done cautiously to 
control the spread of the infectious agents. 
The receiving hospital should be duly 
informed and prepared to accept the patient 
by ensuring they limit the number of people 
establishing contact with the patient, prepare 
the contact precaution isolation room before 
entry, delegate all staffs that will be involved 
in administering care to the patient to a 
minimally essential number, prepare their log 
book for monitoring inow and outow of 
personnel into patient's room and recording 
incidence of signicant symptoms of the 
disease. The personnel and/or relatives 
involved in the transportation of the index 
patient from the contact precaution isolation 
room of referring hospital to the receiving 
hospital should be limited to those providing 
the essential services during the referral 
p r o c e s s ,  a n d  f u l l y  d r e s s e d  i n  t h e 
recommended PPE. The movement of the 
index patient from the admission room of 
referring hospital to the receiving hospital 
should be limited to areas less crowded, less 
visited and with shorter distance while 
competent housekeepers clean and disinfect 
these areas appropriately.
Awareness of cholera disease should be 
communicated suitably to the community 
while rumours and their channels are 
properly monitored and controlled in a 
socially acceptable way. An effective and 
efcient surveillance system, with necessary 
staff and resources, peculiar to infection 
control programs should be developed within 
hospitals and the local/state ministry of health 
in addition to neighbouring regions for proper 
coordination, cooperation, and collaboration 
for sharing data and other resources.
There is need to develop continuous training 
in infection prevention and control in order to 
build the capacity of all health workers and 
the public on basic infection control measures 
applicable while visiting the hospitals and at 
home. This is important to reduce and control 
the future occurrence of cholera.
There is  need to get to that point when and 
where patients can politely request their care 
providers perform hand hygiene before 
establishing contact with them - basic, simple, 
efcient, effective, reliable and timely.
The hospital setting is very important in the 
p r e v e n t i o n  a n d  c o n t r o l  o f  c h o l e r a 
transmission. It also serves as epidemiological
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6. Kanchanachitra C, Lindelow M, Johnston T, 
Hanvoravongchai P, Lorenzo FM, Huong NL, 
et al. Human resources for health in southeast 
Asia: shortages, distributional challenges, and 
international trade in health services. The 
Lancet. 2011;377(9767):769-81.
7. University of Califonia LA. Who rst 
discovered Vibrio Cholera? Los Angeles: 
University of Califonia, Los Angeles;  [cited 
2017 19 September 2017]. Available from: 
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coveredcholera.html.
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Digilio L. Lessons learnt from 12 oral cholera 
vaccine campaigns in resource-poor settings. 
Bulletin of the World Health Organization. 
2017;95(4):303.
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release]. Geneva,Switzerland: World Health 
Organization 16-24 May 2011  2011 
10. Cholera, 2011. Geneva, Switzerland: World 
Health  Organisation, 2012 3 August 2012. 
Report No.: 31-32.
11. Mengel MA, Delrieu I, Heyerdahl L, Gessner 
BD. Cholera outbreaks in Africa.  Cholera 
Outbreaks: Springer; 2014. p. 117-44.
12. Cholera platform against cholera  [cited 2018 
2 2  A p r i l  2 0 1 8 ] .  A v a i l a b l e  f r o m : 
http://www.plateformecholera.info/index.
php/bonus-page/regional-shield-and-
s w o r d - s t r a t e g y / n i g e r i a - c o u n t r y -
page?tmpl=component&print=1.
13. Zanchin G. Considerations on "the sacred 
disease"; by Hippocrates. Journal of the 
History of the Neurosciences. 1992;1(2):91-5.
14. Nigeria, Center, for, Disease, Control. Weekly 
Epidemiological  Report :  OUTBREAK 
PREPAREDNESS: THE ROLE OF A RAPID 
RESPONSE TEAM. . Abuja: Nigeria Center for 
Disease Control, 2017.
15. Adam D. On Hippocrates Footsteps. 
European Journal of Science and Theology. 
2013;9(5):5-16.
16. Son MS, Megli CJ, Kovacikova G, Qadri F, 
Taylor RK. Characterization of Vibrio 
cholerae O1 El Tor Biotype Variant Clinical 
Isolates from Bangladesh and Haiti, Including 
a Molecular Genetic Analysis of Virulence 
Genes. Journal of clinical microbiology. 
2011;49(11):3739-49.
17. Keddy KH, Sooka A, Parsons MB, Njanpop-
Lafourcade BM, Fitchet K, Smith AM. 
Diagnosis of Vibrio cholerae O1 Infection in 
Africa. The Journal of infectious diseases. 
2013;208(suppl_1):S23-S31.
sentinel to alert the public health system to 
36new outbreak.  It is therefore necessary that 
this is continuously strengthened particularly 
at primary care level, and other care level. The 
role of environmental and socioeconomic 
factors, which Nigeria is susceptible to, no 
doubt contribute to it for a long time to come; 
therefore, it is necessary to continue to 
strengthen the healthcare setting to forestall 
transmission while not neglecting the 
community.
CONCLUSION
With the current wave of cholera especially in 
Nigeria, there is need for health practitioners to 
upgrade their skills. This article highlights 
relevant prevention and control measures for 
cholera transmission in clinical setting 
applicable to low-resource settings like Nigeria.
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